Pages that link to "Q15724413"
Jump to navigation
Jump to search
The following pages link to Thrombosis and Haemostasis (Q15724413):
Displayed 50 items.
- Site-directed mutagenesis of coumarin-type anticoagulant-sensitive VKORC1: evidence that highly conserved amino acids define structural requirements for enzymatic activity and inhibition by warfarin (Q24293609) (← links)
- Impaired prothrombinase activity of factor X Gly381Asp results in severe familial CRM+ FX deficiency (Q24294401) (← links)
- Histidine-rich glycoprotein modulates the anticoagulant activity of heparin in human plasma (Q24301916) (← links)
- Platelet activation induced by interleukin-6: evidence for a mechanism involving arachidonic acid metabolism (Q24310763) (← links)
- Formation of tissue factor-factor VIIa-factor Xa complex induces activation of the mTOR pathway which regulates migration of human breast cancer cells (Q24311350) (← links)
- Targeting phosphoinositide 3-kinase gamma to fight inflammation and more (Q24314347) (← links)
- Paris I dysfibrinogenemia: a point mutation in intron 8 results in insertion of a 15 amino acid sequence in the fibrinogen gamma-chain (Q24324200) (← links)
- Inhibition of acute vascular thrombosis in chimpanzees by an anti-human tissue factor antibody targeting the factor X binding site (Q24627747) (← links)
- Tissue factor, protease activated receptors and pathologic heart remodelling (Q26824050) (← links)
- Prostate-specific kallikrein-related peptidases and their relation to prostate cancer biology and detection. Established relevance and emerging roles (Q26865810) (← links)
- Cytoprotective-selective activated protein C therapy for ischaemic stroke (Q27009122) (← links)
- Role of plasma kallikrein in diabetes and metabolism (Q27016431) (← links)
- Long-acting recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in children. Results of a phase 3 trial (Q27342796) (← links)
- Platelet adhesion to podoplanin under flow is mediated by the receptor CLEC-2 and stabilised by Src/Syk-dependent platelet signalling (Q27342857) (← links)
- Pneumococcal phosphoglycerate kinase interacts with plasminogen and its tissue activator (Q27687448) (← links)
- Protein degradation systems in platelets (Q27693902) (← links)
- A novel mutation in intron K of the PROS1 gene causes aberrant RNA splicing and is a common cause of protein S deficiency in a UK thrombophilia cohort (Q28118808) (← links)
- SLFN14-related thrombocytopenia: identification within a large series of patients with inherited thrombocytopenia (Q28119102) (← links)
- Hyperhomocysteinemia, atherosclerosis and thrombosis (Q28138080) (← links)
- Signaling through platelet integrin alpha IIb beta 3: inside-out, outside-in, and sideways (Q28140857) (← links)
- Activated human platelets release connective tissue growth factor (Q28168014) (← links)
- Lepirudin therapy for thrombotic complications in congenital afibrinogenaemia (Q28168458) (← links)
- Therapeutic effect of diagnostic ultrasound on enzymatic thrombolysis. An in vitro study on blood of normal subjects and patients with coronary artery disease (Q28168830) (← links)
- Comparison between ticlopidine and clopidogrel in patients with ST-segment elevation myocardial infarction treated with coronary stenting (Q28168833) (← links)
- GPIb is involved in platelet aggregation induced by mucetin, a snake C-type lectin protein from Chinese habu (Trimeresurus mucrosquamatus) venom (Q28168835) (← links)
- Thromboprophylaxis in medical patients: the role of low-molecular-weight heparin (Q28169084) (← links)
- The risk of bleeding complications in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon (Q28169087) (← links)
- Platelet inhibition by aspirin is diminished in patients during carotid surgery: a form of transient aspirin resistance? (Q28169089) (← links)
- ADP secretion and subsequent P2Y12 receptor signalling play a crucial role in thrombin-induced ERK2 activation in human platelets (Q28169091) (← links)
- A patient with stent thrombosis, clopidogrel-resistance and failure to metabolize clopidogrel to its active metabolite (Q28174186) (← links)
- P2Y12 ADP receptor-dependent tyrosine phosphorylation of proteins of 27 and 31 kDa in thrombin-stimulated human platelets (Q28175292) (← links)
- Streptococcus sanguis-induced platelet activation involves two waves of tyrosine phosphorylation mediated by FcgammaRIIA and alphaIIbbeta3 (Q28175297) (← links)
- Costs of outpatient anticoagulant treatment in patients with cerebral and peripheral arterial occlusive disease (Q28176154) (← links)
- Treatment with simvastatin and low-dose aspirin depresses thrombin generation in patients with coronary heart disease and borderline-high cholesterol levels (Q28176954) (← links)
- Time and dose dependent augmentation of inhibitory effects of abciximab by aspirin (Q28176971) (← links)
- Open multicentre study of the P2T receptor antagonist AR-C69931MX assessing safety, tolerability and activity in patients with acute coronary syndromes (Q28181987) (← links)
- Fc-receptor dependent platelet aggregation induced by monoclonal antibodies against platelet glycoprotein Ib or von Willebrand factor (Q28183143) (← links)
- Antithrombotic strategy in stroke (Q28187573) (← links)
- Hospitalisation for upper gastrointestinal bleeding associated with use of oral anticoagulants (Q28188358) (← links)
- The antiplatelet effect of clopidogrel is not attenuated by statin treatment in stable patients with ischemic heart disease (Q28188543) (← links)
- Increased platelet glycoprotein V levels in patients with coronary and peripheral atherosclerosis--the influence of aspirin and cigarette smoking (Q28189650) (← links)
- Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopy (Q28189662) (← links)
- Coronary stent thrombosis: insights from the porcine coronary stent model (Q28189672) (← links)
- The TF:VIIa complex: clinical significance, structure-function relationships and its role in signaling and metastasis (Q28189906) (← links)
- The role of PAR4 in thrombin-induced thromboxane production in human platelets (Q28190619) (← links)
- Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy (Q28192020) (← links)
- Thrombostatin inhibits cyclic flow variations in stenosed canine coronary arteries (Q28192242) (← links)
- Proline-rich tyrosine kinase 2 and focal adhesion kinase are involved in different phases of platelet activation by vWF (Q28192630) (← links)
- Enoxaparin sodium improves pregnancy outcome in aspirin-resistant antiphospholipid/antiprotein antibody syndromes (Q28192633) (← links)
- Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis (Q28192994) (← links)